JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Audet, R.
Right arrow Articles by Marceau, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Audet, R.
Right arrow Articles by Marceau, F.

Vol. 280, Issue 1, 6-15, 1997

Cardiovascular Effects of Sar-[D-Phe8]des-Arg9-Bradykinin, a Metabolically Protected Agonist of B1 Receptor for Kinins, in the Anesthetized Rabbit Pretreated with a Sublethal Dose of Bacterial Lipopolysaccharide1

Ritchie Audet2, Francis Rioux, Guy Drapeau3 and François Marceau3

Centre de recherche (Université Laval), Hôtel-Dieu de Québec, Québec (Québec) Canada G1R 2J6

We investigated the mechanism of the hypotensive effect of Sar-[D-Phe8]des-Arg9-bradykinin (BK) in lipopolysaccharide-treated anesthetized rabbits. The study involved pharmacokinetic and hemodynamic measurements and tests of antagonism with various drugs. The rate of elimination of Sar-[D-Phe8]des-Arg9-BK from the rabbit plasma was slower than that of Lys-BK, a naturally occurring B1 agonist. The amplitude of the hypotensive effect of Sar-[D-Phe8]des-Arg9-BK was not affected by pretreatment with indomethacin, diclofenac, dazmegrel, NG-nitro-L-arginine, glibenclamide, MK-886, BN-50739, atropine or propranolol, but its duration was shortened by indomethacin and diclofenac. Sar-[D-Phe8]des-Arg9-BK-induced hypotension was associated with decreases of total peripheral resistance, cardiac output, carotid, mesenteric and femoral blood flow, transient reductions followed by secondary increases of vascular resistance in the carotid and femoral beds, reductions of central venous pressure, but no change of hematocrit. Animal pretreatment with diclofenac or hexamethonium abolished the secondary increases of carotid bed vascular resistance caused by the B1 agonist. These and other results suggest that peripheral vasodilation leading to a decrease of total peripheral resistance and a decrease of cardiac output may both contribute consecutively to the hypotensive effect of Sar-[D-Phe8]des-Arg9-BK in this animal model. Inappropriate compensatory responses to arterial hypotension, prostaglandin release, and slow rate of elimination of Sar-[D-Phe8]des-Arg9-BK from the rabbit plasma, may all be at the basis of the prolonged duration of the hypotension caused by the B1 agonist.

Copyright © by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
J.-P. Fortin, L. Gera, J. Bouthillier, J. M. Stewart, A. Adam, and F. Marceau
Endogenous Aminopeptidase N Decreases the Potency of Peptide Agonists and Antagonists of the Kinin B1 Receptors in the Rabbit Aorta
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1169 - 1176.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
Y. Wang, G. Soukhova, M. Proctor, J. Walker, and J. Yu
Bradykinin causes hypotension by activating pulmonary sympathetic afferents in the rabbit
J Appl Physiol, July 1, 2003; 95(1): 233 - 240.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. G. McLean, M. Perretti, and A. Ahluwalia
Kinin B1 receptors and the cardiovascular system: regulation of expression and function
Cardiovasc Res, November 1, 2000; 48(2): 194 - 210.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Houle, M. Landry, R. Audet, J. Bouthillier, D. R. Bachvarov, and F. Marceau
Effect of Allelic Polymorphism of the B1 and B2 Receptor Genes on the Contractile Responses of the Human Umbilical Vein to Kinins
J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 45 - 51.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. Marceau, J.-F. Larrivee, J. Bouthillier, M. Bachvarova, S. Houle, and D. R. Bachvarov
Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1999; 277(6): R1568 - R1578.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
F. Marceau, J. F. Hess, and D. R. Bachvarov
The B1 Receptors for Kinins
Pharmacol. Rev., September 1, 1998; 50(3): 357 - 386.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J.-F. Larrivee, D. R. Bachvarov, F. Houle, J. Landry, J. Huot, and F. Marceau
Role of the Mitogen-Activated Protein Kinases in the Expression of the Kinin B1 Receptors Induced by Tissue Injury
J. Immunol., February 1, 1998; 160(3): 1419 - 1426.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.